PAVAN, Barbara
 Distribuzione geografica
Continente #
NA - Nord America 8.236
EU - Europa 2.115
AS - Asia 1.719
SA - Sud America 16
AF - Africa 7
OC - Oceania 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 12.096
Nazione #
US - Stati Uniti d'America 8.204
CN - Cina 756
UA - Ucraina 562
SG - Singapore 481
IT - Italia 406
DE - Germania 326
TR - Turchia 308
GB - Regno Unito 256
PL - Polonia 162
SE - Svezia 138
FI - Finlandia 135
ID - Indonesia 43
VN - Vietnam 36
FR - Francia 32
CA - Canada 30
IN - India 30
RU - Federazione Russa 21
HK - Hong Kong 17
PK - Pakistan 15
CZ - Repubblica Ceca 14
BE - Belgio 12
LT - Lituania 12
BR - Brasile 9
AT - Austria 7
JP - Giappone 7
NL - Olanda 7
IR - Iran 6
IE - Irlanda 5
NO - Norvegia 5
IQ - Iraq 4
ZA - Sudafrica 4
CH - Svizzera 3
DK - Danimarca 3
EG - Egitto 3
ES - Italia 3
RO - Romania 3
TH - Thailandia 3
TW - Taiwan 3
CL - Cile 2
CO - Colombia 2
IL - Israele 2
PH - Filippine 2
AE - Emirati Arabi Uniti 1
AR - Argentina 1
AU - Australia 1
BG - Bulgaria 1
EU - Europa 1
GR - Grecia 1
KH - Cambogia 1
KR - Corea 1
LA - Repubblica Popolare Democratica del Laos 1
MX - Messico 1
MY - Malesia 1
NZ - Nuova Zelanda 1
PA - Panama 1
PE - Perù 1
PY - Paraguay 1
RS - Serbia 1
UZ - Uzbekistan 1
Totale 12.096
Città #
Fairfield 1.057
Woodbridge 1.040
Jacksonville 634
Houston 625
Chandler 509
Ashburn 482
Santa Clara 475
Ann Arbor 447
Seattle 412
Wilmington 366
Cambridge 361
Singapore 355
Izmir 231
Ferrara 186
Nanjing 177
Warsaw 162
Beijing 161
Princeton 147
Boardman 130
San Diego 96
Addison 72
Milan 63
New York 58
Shanghai 54
Hebei 51
Nanchang 50
Shenyang 48
Jakarta 43
Dong Ket 36
Los Angeles 36
London 32
Bremen 30
Dearborn 29
Falls Church 28
Redwood City 28
Changsha 27
Tianjin 25
Jiaxing 24
Mountain View 23
San Mateo 23
Helsinki 21
Auburn Hills 20
Kunming 18
Jinan 17
Norwalk 17
Bologna 16
Hong Kong 15
Toronto 15
Orange 13
Frankfurt am Main 12
Ottawa 12
Brussels 11
Indiana 11
Tappahannock 10
Des Moines 9
Ningbo 9
Washington 9
Augusta 8
Karachi 8
Munich 8
Philadelphia 8
Dallas 7
Hyderabad 7
Lanzhou 7
Leawood 7
Rome 7
Zhengzhou 7
Guangzhou 6
Hangzhou 6
Olomouc 6
Verona 6
Brooklyn 5
Dublin 5
Florence 5
Hefei 5
Vienna 5
Argenta 4
Brno 4
Falkenstein 4
Hanover 4
Masi Torello 4
New Smyrna Beach 4
Redmond 4
Rovere Veronese 4
Alexandria 3
Amsterdam 3
Bolzano 3
Codevigo 3
Frankfurt Am Main 3
Haikou 3
Islamabad 3
Kilburn 3
Lahore 3
Modena 3
North Bergen 3
Oberengstringen 3
Oslo 3
Pietro 3
Pune 3
Tafahnah al Ashrāf 3
Totale 9.271
Nome #
Nose-to-brain delivery of antiviral drugs: A way to overcome their active efflux? 203
Indomethacin co-crystals and their parent mixtures: does the intestinal barrier recognize them differently? 189
cAMP efflux from human trophoblast cell lines: A role for multidrug resistance protein (MRP)1 transporter 162
Application of the “in-oil nanoprecipitation” method in the encapsulation of hydrophilic drugs in PLGA nanoparticles 154
Geraniol pharmacokinetics, bioavailability and its multiple effects on the liver antioxidant and xenobiotic-metabolizing enzymes 154
Development and characterization of biodegradable nanospheres as delivery systems of anti-ischemic adenosine derivatives. 153
"Low" concentrations of sodium fluoride inhibit neurotransmitter release from the guinea-pig superior cervical ganglion. 142
Responses of peripheral blood mononucleated cells from non-celiac gluten sensitive patients to various cereal sources 140
Brain targeting of resveratrol by nasal administration of chitosan-coated lipid microparticles 140
Conjugation of aspirin with vitamin C: uptake and stability studies 135
17 beta-estradiol stimulates arachidonate release from human amnion-like WISH cells through a rapid mechanism involving a membrane receptor 133
Ascorbic and 6-Br-ascorbic acid conjugates as a tool to increase the therapeutic effects of potentially central active drugs 131
Design, synthesis and in vitro evaluation on HRPE cells of ascorbic and 6-bromoascorbic acid conjugates with neuroactive molecules 131
A novel hybrid drug between two potent anti-tubulin agents as a potential prolonged anticancer approach 131
Modulation of neutrophil phospholipase C activity and cyclic AMP levels by fMLP-OMe analogues 130
Circadian clocks regulate adenylyl cyclase activity rhythms in human RPE cells 130
Nasal chitosan microparticles target a zidovudine prodrug to brain HIV sanctuaries 130
Design, synthesis and activity of ascorbic acid prodrugs of nipecotic, kynurenic and diclophenamic acids, liable to increase neurotropic activity. 129
Biological activity of for-Met-Leu-Phe-OMe analogs: relevant substitutions specifically trigger killing mechanisms in human neutrophils 127
From Physical Mixtures to Co-Crystals: How the Coformers Can Modify Solubility and Biological Activity of Carbamazepine 125
Expression and characterization of vitamin C transporter in the human trophoblast cell line HTR-8/SVneo: effect of steroids, flavonoids and NSAIDs. 123
Binding thermodynamics and intrinsic activity of adenosine A1 receptor ligands 123
Adenosine analogs inhibit acetylcholine release and cyclic AMP synthesis in the guinea-pig superior cervical ganglion 123
Transporter-mediated effects of diclofenamic acid and its ascorbyl pro-drug in the in vivo neurotropic activity of ascorbyl nipecotic acid conjugate 120
Inhibition of amniotic interleukin-6 and prostaglandin E-2 release by ampicillin 120
Molecular mechanism involved in the transport of a prodrug dopamine glycosyl conjugate 115
Formyl-methionyl-leucyl-phenylalanine induces prostaglandin E2 release from human amnion-derived WISH cells by phospholipase C-mediated [Ca2+]i rise 115
Progress in drug delivery to the central nervous system by the prodrug approach 115
Development and characterization of PLGA nanoparticles as delivery systems of a prodrug of zidovudine obtained by its conjugation with ursodeoxycholic acid 114
Prostaglandin E-2 inhibits proliferation and migration of HTR-8/SVneo cells, a human trophoblast-derived cell line 113
Vitamin C and 6-amino-vitamin C conjugates of diclofenac: synthesis and evaluation 112
Adenylyl cyclase/cAMP system involvement in the antiangiogenic effect of somatostatin in the retina. Results from transgenic mice 109
Biological activity of somatostatin receptors in GC rat tumour somatotrophs: evidence with sst1-sst5 receptor-selective nonpeptidyl agonists. 109
The role and modulation of the oxidative balance in pregnancy 108
Evidence for the presence of N-formyl-methionyl-leucyl-phenylalanine (fMLP) receptor ligands in human amniotic fluid and fMLP receptor modulation by physiological labour 108
Can pharmaceutical co-crystals provide an opportunity to modify the biological properties of drugs? 108
Uptake in the Central Nervous System of Geraniol Oil Encapsulated in Chitosan Oleate Following Nasal and Oral Administration 108
Poly(lactic acid) microspheres for the sustained release of antiischemic agents 107
Influence of oxytocin on prostaglandin E-2, intracellular calcium, and cyclic adenosine monophosphate in human amnion-derived (WISH) cells 107
Biochemical and pharmacological characterization of adenosine A1 receptors in eel (Anguilla anguilla) brain. 107
Brain uptake of a Zidovudine prodrug after nasal administration of solid lipid microparticles 106
Compensatory changes in the hippocampus of somatostatin knockout mice: upregulation of somatostatin receptor 2 and its function in the control of bursting activity and synaptic transmission. 105
Dopamine-sensitive adenylyl cyclases in neuronal development: physiopathological and pharmacological implications. 105
Potential therapeutic effects of odorants through their ectopic receptors in pigmented cells 104
Temperature dependence of the affinity enhancement of selective adenosine A1 receptor agonism: A thermodynamic analysis 102
Adenosine enhances acetylcholine receptor channel openings and intracellular calcium 'spiking' in mouse skeletal myotubes. 102
Nuclear Retinoic Acid Receptor Beta as a Tool in Chemoprevention Trials 100
Prodrugs and Endogenous Transporters: Are They Suitable Tools for Drug Targeting into the Central Nervous System? 99
Beta-adrenoreceptor agonism influences retinal responses to hypoxia in a model of retinopathy of prematurity. 99
Processing of adenosine receptor agonists in rat and human whole blood. 98
Interactions between the nitric oxide and prostaglandin E2 biosynthetic pathways in human amnion-like WISH cells. 98
The cyclooxygenase-2/prostaglandin E2 pathway is involved in the somatostatin-induced decrease of epileptiform bursting in the mouse hippocampus. 97
Bile salt-coating modulates the macrophage uptake of nanocores constituted by a zidovudine prodrug and enhances its nose-to-brain delivery 96
Effect of different classes of antibiotics on amniotic prostaglandin E release 96
Use of glucocorticoids in pregnancy. 95
17β-estradiol modulates prostaglandin E2 release from human amnion-derived WISH cells 95
Somatostatin (SRIF) modulates distinct signaling pathways in rat pituitary tumor cells; negative coupling of SRIF receptor subtypes 1 and 2 to arachidonic acid release 95
An RPE cell line as a useful in vitro model for studying retinoic acid receptor beta: expression and affinity. 94
From crystal to solution and across the membranes: the case of carbamazepine co-crystals 94
null 93
Characterisation of potential adenosine A1 receptor prodrugs of adenosine derivatives with antiischemic properties 92
High glucose-induced barrier impairment of human retinal pigment epithelium is ameliorated by treatment with Goji berry extracts through modulation of cAMP levels. 92
Drug release from pharmaceutical co-crystals: Are therapeutic and safety properties of active pharmaceutical substances retained? 92
Involvement of the cAMP-dependent pathway in the reduction of epileptiform bursting caused by somatostatin in the mouse hippocampus 91
WISH cells as a model for the "in vitro" study of amnion pathophysiology. 91
Odorants could elicit repair processes in melanized neuronal and skin cells 88
Cross-talk between nitridergic and prostaglandinergic pathways in amnion-like WISH cells 87
Inhibition of amniotic prostaglandin E release by ampicillin 86
Somatostatin coupling to adenylyl cyclase activity in the mouse retina 85
Controlled release studies of antiischemic agents encapsulated in poly(lactic acid) nanoparticles. 85
Neuroactive molecules and their pro-drugs obtained by conjugation with vitamin c: studies of delivery into the brain. 83
null 83
null 83
Binding therodynamics and intrinsic activity of adenosine A1 receptor ligands: a model of their heart rate inhibition power. 81
β-methasone, progesterone and RU-486 (mifepristone) exert similar effects on connexin expression in trophoblast-derived HTR-8/SVneo cells. 81
METODO PER MODULARE L'ASSORBIMENTO FAGOCITARIO DI UN PRINCIPIO ATTIVO O UN SUO PRECURSORE DA PARTE DI MACROFAGI 81
null 81
Quercetin and quercetin-3-O-glucoside interact with different components of the cAMP signaling cascade in human retinal pigment epithelial cells 80
The Role of Combined Penetration Enhancers in Nasal Microspheres on In Vivo Drug Bioavailability 80
Thermodynamic in vitro studies as a method to investigate the in vivo behaviour of adenosine A1 receptor ligands. 79
Brain targeting of neuroactive drugs: studies of their transport mechanisms as conjugated with vitamin C or glucose. 77
Estrogens metabolites in the release of inflammatory mediators from human amnion-derived cells 76
Thermodynamic in vitro studies as a method to investigate the pharmacodynamic behavior of adenosine A(1) receptor ligands 76
Coniugati dell’acido ascorbico ad attività neurotropica. 75
Cobalt chloride induced hypoxia and lipid peroxidation in HRPE cells 74
Retinal pigment epithelial cells as a therapeutic tool and target against retinopathies 74
Role of oxidative stress in chemical hypoxia induced apoptosis 72
Uptake and stability studies of diclofenamic acid and its pro-drug obtained by conjugation with vitamin C 71
Vitamin C prodrugs of diclophenamic acid: stability studies and uptake analysis on HRPE cells. 70
null 70
Binding thermodynamics and intrinsic activity of adenosine A1 receptor ligands: a model of their heart rate inhibition power. 69
Neuropharmaceutical agents and their pro-drug obtained by conjugation with vitamin C: studies of delivery into the brain. 68
Synthesis and characterization of potential adenosine A1 receptor prodrugs 68
Evidence for a circadian clock in HRPE cells controlling adenylyl cyclase activity rhythms 67
Release modulation of hydrophilic drugs from polymeric nanoparticles produced by in-oil nanoprecipitation process 67
Cancer stem cells and nanomedicine: new opportunities to combat multidrug resistance? 67
Conjugation of Dopamine and an A2A Adenosine Receptor Antagonist: a possible approach for the treatment of Parkinson’s Disease. 66
Studies for delivery into the brain of neurotropic drugs and their prodrugs conjugated with vitamin C. 64
In vitro behaviour of N6-cyclopentyladenosine-loaded nanoparticles prepared via a non-aqueous nanoparecipitation method. 64
Stereochimica e tossicità 64
Totale 10.206
Categoria #
all - tutte 59.062
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 592
Totale 59.654


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.413 0 0 0 0 0 286 216 293 190 272 109 47
2020/20211.824 136 134 98 165 78 186 54 207 78 332 233 123
2021/20221.315 37 174 103 50 44 47 57 65 53 99 111 475
2022/20231.223 142 60 45 148 223 185 43 95 151 8 78 45
2023/2024720 68 93 36 21 57 90 31 36 17 14 30 227
2024/20251.279 69 70 270 155 425 290 0 0 0 0 0 0
Totale 12.317